Pharma

Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTMand DOTAREM®, following the receipt of...

 Usnoflast, is a “First-in-class” NLRP3 inhibitor to demonstrate proof-of-concept in Phase 2(a) clinical study in ALS patients Usnoflast was well-tolerated...

NE BUSINESS BUREAU CHENNAI, SEPT 2 Meril a global leader in advanced medical solutions, has announced the launch of its...

The proposed unit of Kaynes Semicon Pvt Ltd will be setup with an investment of Rs 3,300 crore In June,...

This is the fifth ANDA approval for Zydus in the transdermal portfolio, leveraging the group’s strengths in the manufacturing of...

 Zydus receives final approval from USFDA for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg Eligible for...

This trailblazing work on Covid-19 vaccine has been published in the world’s leading science Journal Nature Communications NDDB and its...

The acquisition will also mark Zydus’ foray into specialised biotech products for health and nutrition, specifically catering to consumers who...

It is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI) The treatment of...

Gujarat accounts for just under 10% of total retail investors, as per BSE data Over the last 5 years, Ahmedabad’s...